drugset / Trial / NCT01039961
PK Study of IV Formulation of GW856553
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of an IV infusion of GW856553 in healthy volunteers.
Timeline
- Start
- 2010-02-02
- Primary completion
- 2010-04-15
- Completion
- 2010-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losmapimod | Small molecule | 1 mg | Intravenous |
| Subject | Losmapimod | Small molecule | 15 mg | Intravenous |